Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what information is provided by NHS England to patients with blood cancer on CAR-T cell therapies.

Clinicians are uniquely placed to explain to individual patients what treatments might or might not benefit them, with reference to their circumstances. NHS England is working with providers, patient groups and manufacturers to ensure appropriate information is made available to help clinicians and patients make informed treatment decisions as Chimeric Antigen Receptor T Cell (CAR-T) therapy starts to be made available through the National Health Service.